Invasive and in vivo near-infrared determination of pH

• US 6,061,581 A
• Filed: 08/10/1998
• Issued: 05/09/2000
• Est. Priority Date: 07/06/1992
• Status: Expired due to Term

• Current Assignee: National Technology & Engineering Solutions Of Sandia LLC (Honeywell International Inc.), Luminous Medical, Inc., Rio Grande Medical Technologies Incorporated
• Original Assignee: Sandia Corporation (Martin Marietta Corporation)
• Inventors: Robinson, Mark R., Alam, Mary K.
• Primary Examiner(s): Dvorak, Linda C. M.
• Assistant Examiner(s): YARNELL, BRYAN KEITH
• Application Number:
  US09/131,458
• Time in Patent Office: 638 Days
• Field of Search: 600/310, 600/322, 600/323, 600/326, 600/327, 600/341, 600/342, 356/39-41
• US Class Current: 600/310
• CPC Class Codes: A61B 5/02007 Evaluating blood vessel condition, e.g. elasticity, compliance
• CPC Class Codes: A61B 5/14539 for measuring pH
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/352 Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
• CPC Class Codes: A61B 5/6826 Finger
• CPC Class Codes: A61B 5/6838 Clamps or clips

Abstract

Methods for determining invasively and in vivo pH in a human. The invasive method includes the steps of: generating light at three or more different wavelengths in the range of 1000 nm to 2500 nm; irradiating blood; measuring the intensities of the wavelengths emerging from the blood to obtain a set of at least three spectral intensities v. wavelengths; and determining the unknown values of pH. The determination of pH is made by using measured intensities at wavelengths that exhibit change in absorbance due to histidine titration. Histidine absorbance changes are due to titration by hydrogen ions. The determination of the unknown pH values is performed by at least one multivariate algorithm using two or more variables and at least one calibration model. The determined pH values are within the physiological ranges observed in blood containing tissue.

Claims

1. A method of determining pH in blood invasively, in vivo, and within the physiological ranges observed in said blood utilizing blood spectra which spectra contains histidine information, said method comprising steps of:

a) generating light at three or more different wavelengths, said wavelengths being in the range of 1000 nm to 2500 nm;

b) invasively irradiating said blood with said wavelengths so that there is differential attenuation of at least some intensities of wavelengths, said wavelengths dependent differential attenuation being a function of said blood, including histidine in said blood;

c) measuring at least a portion of said intensities of said wavelengths emerging from said blood to obtain a set of at least three spectral intensities v. wavelengths; and

d) estimating said value of said pH from said measured intensities by utilizing wavelength dependent differential attenuation derived from said histidine, said value being within said physiological ranges.

2. The method as set forth in claim 1, utilizing wavelength dependent differential attenuation derived form histidine, which exhibits a sensitivity due to changes in pH.

3. The method of claim 1, wherein said wavelengths used for said estimation of pH are those known to exhibit a differential attenuation due to hydrogen ions reacting with histidine.

4. The method as set forth in claim 3, wherein said wavelengths are in the range of 1000-1300 nm.

5. The method as set forth in claim 4, wherein said wavelengths include one or more of 1042, 1111 and 1163 nm.

6. The method as set forth in claim 3, wherein said wavelengths are in the range of 1300-2500 nm.

7. The method as set forth in claim 6, wherein said wavelengths are in the range of 1500-1820 nm.

8. The method as set forth in claim 7, wherein said wavelengths include 1600 nm.

9. The method as set forth in claim 6, wherein said wavelengths are in the range of 2040-2500 nm.

10. The method as set forth in claim 9, wherein said wavelengths include one or more of 2060-2115, 2160, 2225-2235 and 2360 nm.